Abstract
Guanine nucleotide binding protein-like 3-like (GNL3L) is a nucleolar protein and the vertebrate paralogue of nucleostemin (NS). We previously reported that nucleoplasmic mobilization of NS stabilizes MDM2 (mouse double minute 2). Here, we investigated the role of GNL3L as a novel MDM2 regulator. We found that GNL3L binds MDM2 in vivo and displays the same function as NS in stabilizing MDM2 protein and preventing its ubiquitylation. The interaction between GNL3L and MDM2 also takes place in the nucleoplasm. However, the MDM2 regulatory activity of GNL3L occurs constitutively and does not so much depend on the nucleolar release mechanism as NS does. GNL3L depletion triggers G2/M arrest in the p53-wild-type HCT116 cells more than in the p53-null cells, and upregulates specific p53 targets (that is, Bax, 14-3-3σ and p21) without affecting the ubiquitylation or stability of p53 proteins. The inhibitory activity of GNL3L on p53-mediated transcription correlates with the increased expression of GNL3L and reduced expression of 14-3-3σ and p21 in human gastrointestinal tumors. This work shows that in contrast to most nucleolar proteins that negatively control MDM2, GNL3L and NS are the only two that are designed to stabilize MDM2 protein under basal or induced condition, respectively, and may act as tumor-promoting genes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC et al. (2003). Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 89: 1235–1249.
Beekman C, Nichane M, De Clercq S, Maetens M, Floss T, Wurst W et al. (2006). Evolutionarily conserved role of nucleostemin: controlling proliferation of stem/progenitor cells during early vertebrate development. Mol Cell Biol 26: 9291–9301.
Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP et al. (1998). Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497–1501.
Dai MS, Sun XX, Lu H . (2008). Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2. Mol Cell Biol 28: 4365–4376.
Dai MS, Zeng SX, Jin Y, Sun XX, David L, Lu H . (2004). Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol 24: 7654–7668.
Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM . (2000). Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 275: 8945–8951.
Fu D, Collins K . (2007). Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. Mol Cell 28: 773–785.
Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S et al. (1997). 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1: 3–11.
Huang M, Itahana K, Zhang Y, Mitchell BS . (2009). Depletion of guanine nucleotides leads to the Mdm2-dependent proteasomal degradation of nucleostemin. Cancer Res 69: 3004–3012.
Jin A, Itahana K, O'Keefe K, Zhang Y . (2004). Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol 24: 7669–7680.
Kubbutat MH, Ludwig RL, Levine AJ, Vousden KH . (1999). Analysis of the degradation function of Mdm2. Cell Growth Differ 10: 87–92.
Kurki S, Peltonen K, Latonen L, Kiviharju TM, Ojala PM, Meek D et al. (2004). Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 5: 465–475.
Ma H, Pederson T . (2007). Depletion of the nucleolar protein nucleostemin causes G1 cell cycle arrest via the p53 pathway. Mol Biol Cell 18: 2630–2635.
Maki N, Takechi K, Sano S, Tarui H, Sasai Y, Agata K . (2007). Rapid accumulation of nucleostemin in nucleolus during newt regeneration. Dev Dyn 236: 941–950.
Meng L, Lin T, Tsai RY . (2008). Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival. J Cell Sci 121: 4037–4046.
Meng L, Yasumoto H, Tsai RY . (2006). Multiple controls regulate nucleostemin partitioning between nucleolus and nucleoplasm. J Cell Sci 119: 5124–5136.
Meng L, Zhu Q, Tsai RY . (2007). Nucleolar trafficking of nucleostemin family proteins: common versus protein-specific mechanisms. Mol Cell Biol 27: 8670–8682.
Nikpour P, Mowla SJ, Jafarnejad SM, Fischer U, Schulz WA . (2009). Differential effects of nucleostemin suppression on cell cycle arrest and apoptosis in the bladder cancer cell lines 5637 and SW1710. Cell Prolif 42: 762–769.
Ohmura M, Naka K, Hoshii T, Muraguchi T, Shugo H, Tamase A et al. (2008). Identification of stem cells during prepubertal spermatogenesis via monitoring of nucleostemin promoter activity. Stem Cells 26: 3237–3246.
Pederson T, Tsai RY . (2009). In search of nonribosomal nucleolar protein function and regulation. J Cell Biol 184: 771–776.
Siddiqi S, Gude N, Hosoda T, Muraski J, Rubio M, Emmanuel G et al. (2008). Myocardial induction of nucleostemin in response to postnatal growth and pathological challenge. Circ Res 103: 89–97.
Tao W, Levine AJ . (1999). P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc Natl Acad Sci USA 96: 6937–6941.
Taylor WR, Stark GR . (2001). Regulation of the G2/M transition by p53. Oncogene 20: 1803–1815.
Tsai RY, McKay RD . (2002). A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev 16: 2991–3003.
Tsai RY, Meng L . (2009). Nucleostemin: a latecomer with new tricks. Int J Biochem Cell Biol 41: 2122–2124.
Wallace M, Worrall E, Pettersson S, Hupp TR, Ball KL . (2006). Dual-site regulation of MDM2 E3-ubiquitin ligase activity. Mol Cell 23: 251–263.
Yasumoto H, Meng L, Lin T, Zhu Q, Tsai RY . (2007). GNL3L inhibits activity of estrogen-related receptor gamma by competing for coactivator binding. J Cell Sci 120: 2532–2543.
Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA et al. (2003). Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 23: 8902–8912.
Zhu Q, Meng L, Hsu JK, Lin T, Teishima J, Tsai RY . (2009). GNL3L stabilizes the TRF1 complex and promotes mitotic transition. J Cell Biol 185: 827–839.
Zhu Q, Yasumoto H, Tsai RY . (2006). Nucleostemin delays cellular senescence and negatively regulates TRF1 protein stability. Mol Cell Biol 26: 9279–9290.
Acknowledgements
We gratefully acknowledge Bert Vogelstein of the Johns Hopkins Oncology Center for providing the HCT116 cells. This work is supported by NCI-PHS grant R01 CA113750 to RY Tsai.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Meng, L., Hsu, J. & Tsai, R. GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest. Oncogene 30, 1716–1726 (2011). https://doi.org/10.1038/onc.2010.550
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.550
Keywords
This article is cited by
-
GNL3L promotes autophagy via regulating AMPK signaling in esophageal cancer cells
Medical Oncology (2023)
-
Characterization of stem cell subtypes and prognostic signature in hepatocellular carcinoma
Journal of Cancer Research and Clinical Oncology (2023)
-
p53 Configures the G2/M arrest response of nucleostemin-deficient cells
Cell Death Discovery (2015)
-
Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells
BMC Biology (2014)